Farther Finance Advisors, LLC

Position in ABSI — Absci Corp

CIK 1992825 SAN FRANCISCO, CA

Position in ABSI

as of Jun 30, 2026 · filed Jul 17, 2026 Compact

Position Value

$115,471

+$112,732 QoQ

Shares Held

9,963

+991.2% QoQ

Ownership

0.006%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#160

of 195 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Farther Finance Advisors, LLC holds $15,699,251 across 282 Biotechnology names. ABSI ranks #26 (0.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	4,922	$2,444,905
2	MRNA	Moderna, Inc.	15,429	$1,080,492
3	ARWR	Arrowhead Pharmaceuticals, Inc.	12,088	$985,292
4	HALO	Halozyme Therapeutics, Inc.	11,241	$879,833
5	EXEL	Exelixis, Inc.	14,171	$771,044
6	REGN	Regeneron Pharmaceuticals, Inc.	1,075	$670,305
7	VKTX	Viking Therapeutics, Inc.	15,171	$591,820
8	BMRN	Biomarin Pharmaceutical Inc	7,871	$450,378

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$115,471	9,963	+991.2%	Shares	Sole	2026-07-17
2026-03-31	$2,739	913	-37.6%	Shares	Sole	2026-04-07
2025-12-31	$5,105	1,463	-0.3%	Shares	Sole	2026-01-23
2025-09-30	$4,462	1,468	+24366.7%	Shares	Sole	2025-10-14
2025-06-30	$15	6	+500.0%	Shares	Sole	2025-07-11
2025-03-31	$2	1	-100.0%	Shares	Sole	2025-04-14
2024-12-31	$19,521	7,451	-60.5%	Shares	Sole	2025-02-10
2024-09-30	$72,106	18,876	+119.5%	Shares	Sole	2024-10-29
2024-06-30	$26,491	8,601	+860000.0%	Shares	Sole	2024-07-31
2024-03-31	$5	1	-100.0%	Shares	Sole	2024-05-14
2023-12-31	$124,744	29,701	-94.0%	Shares	Sole	2024-02-15
2023-09-30	$650,180	492,561	+7.7%	Shares	Sole	2023-11-14
2023-06-30	$695,047	457,268	+5.4%	Shares	Sole	2024-05-14
2023-03-31	$759,356	433,918	+15.6%	Shares	Sole	2024-05-14
2022-12-31	$788,285	375,374	—	Shares	Sole	2023-09-12
No filing history on record for this holder in this stock.